There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders. including Spinocerebellar Ataxia Type-3 (SCA3). Here. we augment the proteostasis network of Drosophila SCA3 models with Hsp104. https://www.marcelovicente.com/product-category/color-depositing-mask-platinum/
Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.
Internet 2 hours 11 minutes ago ljthacz4a5z7Web Directory Categories
Web Directory Search
New Site Listings